Merck & Co said on Friday it expects to make licensed doses of its recently approved Ebola vaccine available in the third quarter of 2020 and price the single-dose injection at the lowest possible access price for poor and middle-income countries.
from Reuters: Company News https://ift.tt/34K1P9M
via IFTTT
0 comments:
Post a Comment